104 Results for "

amyloid aggregation

" in MedChemExpress (MCE) Product Catalog:
Products (104)

104 Results for "amyloid aggregation" in MCE Product Catalog:

Cat. No.: HY-D3069
CAS No.: 2892545-08-1
Research Areas:  

Neurological Disease

DNTPH is a near-infrared (NIR) aggregation-induced emission (AIE) fluorescent probe used for imaging β-amyloid (Aβ) aggregates. Designed by balancing hydrophobic and hydrophilic groups, DNTPH achieves selective binding to Aβ42 fibrils and generates a near-infrared fluorescent signal with high signal-to-noise ratio. Upon binding to Aβ42 fibrils, DNTPH exhibits enhanced fluorescence, while also inhibiting Aβ42 fibril formation, promoting fibril depolymerization, attenuating Aβ-induced neurotoxicity, and improving cognitive function in Alzheimer's disease (AD) mice. DNTPH can be used in Alzheimer's disease research .
loading...
    loading...
Cat. No.: HY-N7046R
CAS No.: 142797-34-0
Synonyms: Silibinin B (Standard)
Silybin (Silibinin B) (Standard) is the analytical standard of Silybin B (HY-N7046). This product is intended for research and analytical applications. Silybin B (Silibinin B) is an orally active amyloid-β aggregation inhibitor and ATR pathway activator, that can cross the blood-brain barrier. Silybin B inhibits Aβ fibril formation and promotes amorphous aggregate formation, while activating the ATR-mediated DNA damage repair pathway and inhibiting JNK/p38 MAPK signaling. Silybin B can reduce Cisplatin (HY-17394)-induced neuronal DNA damage and apoptosis. Silybin B has anti-oxidative stress, cell cycle regulation and neuroprotective activities. Silybin B is mainly used in the study of Alzheimer's disease and Cisplatin chemotherapy-related neurotoxicity .
loading...
    loading...
Cat. No.: HY-N7046S
Synonyms: Silibinin B-d3
Silybin B-d3 (Silibinin B-d3) is a deuterated Silybin B (HY-N7046). Silybin B (Silibinin B) is an orally active amyloid-β aggregation inhibitor and ATR pathway activator, that can cross the blood-brain barrier. Silybin B inhibits Aβ fibril formation and promotes amorphous aggregate formation, while activating the ATR-mediated DNA damage repair pathway and inhibiting JNK/p38 MAPK signaling. Silybin B can reduce Cisplatin (HY-17394)-induced neuronal DNA damage and apoptosis. Silybin B has anti-oxidative stress, cell cycle regulation and neuroprotective activities. Silybin B is mainly used in the study of Alzheimer's disease and Cisplatin chemotherapy-related neurotoxicity .
loading...
    loading...
Cat. No.: HY-N8693
CAS No.: 362472-81-9
Withanoside IV is an orally active, blood-brain barrier-permeable withanolide derivative. Withanoside IV specifically binds to the Sudlow I site of HSA, induces secondary structural changes in HSA, and forms stable HSA complexes. Withanoside IV inhibits the enzymatic activity of COX-2. Withanoside IV induces axonal regeneration, peripheral nervous system myelination and increased axonal density in spinal cord tissue, reduces reactive gliosis-related changes, and improves hindlimb motor function. Withanoside IV binds to amyloid-β 1-42 to inhibit its aggregation, induces neurite outgrowth and synapse reconstruction, repairs damaged axons and dendrites, enhances mitochondrial biogenesis, exerts neuroprotective effects via the BDNF and SIRT1 signaling pathways, reduces ROS production and neuronal apoptosis, and ameliorates memory deficits. Withanoside IV inhibits the activity of the SARS-CoV-2 main protease. Withanoside IV can be used in research related to spinal cord injury, Alzheimer's disease, and coronavirus disease 2019 (COVID-19) .
loading...
    loading...